Cohance Lifesciences Limited (COHANCE)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 330.17 483.58 981.37 481.58 567.55
YOY Revenue Growth % - - - - 71.9%
Other Income 6.63 13.10 39.40 6.12 -0.79
Total Income 336.80 496.68 1,020.77 487.70 566.76
Total Expenses + 280.48 417.54 820.91 417.41 493.81
Cost of Materials Consumed 66.98 175.16 363.35 193.29 134.63
Employee Benefit Expense 52.72 103.43 198.53 85.09 96.81
Other Expenses 79.64 129.96 263.41 136.78 142.78
Operating Profit 49.69 66.04 160.46 64.17 73.74
OPM % 15% 13.7% 16.4% 13.3% 13%
Profit Before Tax + 56.32 71.04 191.76 65.43 56.44
Tax Expense 11.98 18.47 44.90 18.14 21.88
Tax % 21.3% 26% 23.4% 27.7% 38.8%
Profit After Tax 44.34 52.57 146.86 47.29 34.56
EPS (Basic) 1.74 1.38 3.84 1.24 0.90

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 1,093.51
YOY Revenue Growth % -
Other Income 53.98
Total Income 1,147.49
Total Expenses + 796.14
Cost of Materials Consumed 212.51
Employee Benefit Expense 198.30
Other Expenses 233.60
Operating Profit 297.37
OPM % 27.2%
Profit Before Exceptional 351.35
Exceptional Items 0.00
Profit Before Tax + 351.35
Tax Expense 79.64
Tax % 22.7%
Profit After Tax 271.71
EPS (Basic) 10.67

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 1,879.05
Property, Plant & Equipment 623.44
Capital Work in Progress 253.15
Non-Current Investments 924.64
Goodwill 60.25
Other Intangible Assets 1.10
Current Assets + 708.76
Inventories 154.12
Trade Receivables 242.47
Cash and Cash Equivalents 19.36
Current Investments 191.56
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 25.46
Other Equity 2,290.09
Non-Current Liabilities 58.73
Current Liabilities 213.53
Total Liabilities 272.26

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities 301.03
Cash from Investing Activities -320.94
Cash from Financing Activities 20.81
Net Increase/Decrease in Cash 0.90